RS88803A - Novel-arylsulfonamide compounds for the treatment of obesity type ii diabetes and cns-disorders - Google Patents
Novel-arylsulfonamide compounds for the treatment of obesity type ii diabetes and cns-disordersInfo
- Publication number
- RS88803A RS88803A YUP-888/03A YUP88803A RS88803A RS 88803 A RS88803 A RS 88803A YU P88803 A YUP88803 A YU P88803A RS 88803 A RS88803 A RS 88803A
- Authority
- RS
- Serbia
- Prior art keywords
- diabetes
- disorders
- treatment
- cns
- novel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/08—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/12—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The present invention relates to substituted bis-arylsulfonamide and arylsulfonamide compounds of the general formula (I) or the formula (II), which compounds are potentially useful for the prophylaxis and treatment of medical conditions relating to obesity, type II diabetes and/or disorders of the central nervous system.
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0101660A SE0101660D0 (en) | 2001-05-11 | 2001-05-11 | New compounds |
SE0101659A SE0101659D0 (en) | 2001-05-11 | 2001-05-11 | New compounds |
US29413201P | 2001-05-29 | 2001-05-29 | |
US29410201P | 2001-05-29 | 2001-05-29 | |
SE0101958A SE0101958D0 (en) | 2001-06-05 | 2001-06-05 | New compounds |
PCT/SE2002/000906 WO2002092585A1 (en) | 2001-05-11 | 2002-05-08 | Novel, arylsusfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
RS88803A true RS88803A (en) | 2007-02-05 |
Family
ID=43645931
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YUP-888/03A RS88803A (en) | 2001-05-11 | 2002-05-08 | Novel-arylsulfonamide compounds for the treatment of obesity type ii diabetes and cns-disorders |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR100922486B1 (en) |
RS (1) | RS88803A (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DZ2376A1 (en) * | 1996-12-19 | 2002-12-28 | Smithkline Beecham Plc | New sulfonamide derivatives process for their preparation and pharmaceutical compositions containing them. |
DE19941559A1 (en) * | 1999-09-01 | 2001-03-15 | Aventis Pharma Gmbh | Use of bissulfonamides for the preparation of medicaments for the prophylaxis or treatment of hyperlipidemia |
-
2002
- 2002-05-08 RS YUP-888/03A patent/RS88803A/en unknown
- 2002-05-08 KR KR1020037014656A patent/KR100922486B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR20040007549A (en) | 2004-01-24 |
KR100922486B1 (en) | 2009-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA03010232A (en) | Novel, arylsusfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders. | |
MXPA03011083A (en) | Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes. | |
EA200600048A1 (en) | BENZAZEPIN DERIVATIVES USED TO TREAT DISEASES ASSOCIATED WITH 5-HT RECEPTOR | |
JO2764B1 (en) | Indole derivatives or benzimidazole derivatives for modulating ikappab kinase | |
DE60229530D1 (en) | SUBSTITUTED PIPERAZINE AS MODULATORS OF MELANOCORTINRECEPTOR | |
HK1092467A1 (en) | N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses n- | |
GEP20074197B (en) | 5ht2c receptor modulators | |
MXPA04006280A (en) | Spiroazacyclic compounds as monoamine receptor modulators. | |
UA84390C2 (en) | Amide derivatives as glucokinase activators | |
UA83194C2 (en) | Pyrimidine derivatives and their use as cb2 modulators | |
HK1094425A1 (en) | Substituted 2-aminotetralines for the preventive treatment of parkinson's disease | |
GB0222495D0 (en) | Compounds | |
CA2449729A1 (en) | Prodrugs of gaba analogs, compositions and uses thereof | |
IN2006KO01346A (en) | ||
MY141528A (en) | Anilinopyrazole derivatives useful for the treatment of diabetes | |
SE0403006D0 (en) | New compounds | |
GB0111186D0 (en) | Novel compounds | |
AU2003260436A1 (en) | Pyrimidine compounds | |
IL161047A0 (en) | Pyrazole derivatives for increasing endogenous testosterone levels | |
MXPA04003910A (en) | Use of irbesartan for the preparation of medicaments that are used to prevent or treat pulmonary hypertension. | |
RS88803A (en) | Novel-arylsulfonamide compounds for the treatment of obesity type ii diabetes and cns-disorders | |
TW200503672A (en) | 2-aminobenzoyl derivatives | |
TW200505435A (en) | Treatment of ocular disorders | |
SE0102048D0 (en) | New Compounds | |
DE60326348D1 (en) | MACROCLES FOR THE TREATMENT OF CANCER DISORDERS |